Mill Creek Capital Advisors, LLC Pfizer Inc Transaction History

Mill Creek Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $10,684 - $12,520	-423 Reduced 5.44%	7,348 $205,000
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $35,909 - $41,235	-1,387 Reduced 15.15%	7,771 $215,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $39,691 - $51,554	1,519 Added 19.88%	9,158 $263,000
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $151,111 - $176,634	-4,709 Reduced 38.14%	7,639 $253,000
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $799,443 - $924,938	-22,133 Reduced 64.19%	12,348 $452,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $4.77 Million - $6.21 Million	-121,016 Reduced 77.83%	34,481 $1.41 Million
Q4 2022 May 25, 2023	BUY	$41.75 - $54.5 $50,058 - $65,345	1,199 Added 3.48%	35,680 $1.83 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $6.49 Million - $8.47 Million	155,497 New	155,497 $0

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Mill Creek Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mill Creek Capital Advisors, LLC with notifications on news.